scholarly article | Q13442814 |
P2093 | author name string | Hiroshi Suzuki | |
Hassan Zaraket | |||
Reiko Saito | |||
Ghassan S Dbaibo | |||
Mohammad Saleh | |||
Rami Mahfouz | |||
Souha S Kanj | |||
Zeina Kanafani | |||
George F Araj | |||
Rima Hanna-Wakim | |||
Ahmad Chmaisse | |||
Sarah Chamseddine | |||
Sima L Sharara | |||
Hady Ezzeddine | |||
Aia Assaf-Casals | |||
Danielle Fayad | |||
Sarah Khafaja | |||
Rouba Sayegh | |||
Zeina Saleh | |||
P2860 | cites work | The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis | Q28077490 |
Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies | Q28260818 | ||
Implementing hospital-based surveillance for severe acute respiratory infections caused by influenza and other respiratory pathogens in New Zealand | Q30209109 | ||
Bacterial and viral infections associated with influenza. | Q30353612 | ||
Asymptomatic ratio for seasonal H1N1 influenza infection among schoolchildren in Taiwan. | Q30358892 | ||
Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. | Q30361230 | ||
Characterization of human Influenza Viruses in Lebanon during 2010-2011 and 2011-2012 post-pandemic seasons. | Q30367674 | ||
Surveillance for severe acute respiratory infections (SARI) in hospitals in the WHO European region - an exploratory analysis of risk factors for a severe outcome in influenza-positive SARI cases | Q30370529 | ||
Clinical characteristics and outcomes in children hospitalised with pandemic influenza A/H1N1/09 virus infection – a nationwide survey by the Pediatric Infectious Diseases Group of Switzerland. | Q30377252 | ||
Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season | Q30389837 | ||
Genetic diversity and antiviral drug resistance of pandemic H1N1 2009 in Lebanon | Q30402592 | ||
Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination? | Q30402798 | ||
Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza | Q30413783 | ||
Encephalitis and encephalopathy associated with an influenza epidemic in Japan | Q33343686 | ||
Influenza and other respiratory virus infections in outpatients with medically attended acute respiratory infection during the 2011-12 influenza season. | Q33756909 | ||
Results from the first six years of national sentinel surveillance for influenza in Kenya, July 2007-June 2013 | Q33794206 | ||
Clinical Characteristics of Influenza-Associated Pneumonia of Adults: Clinical Features and Factors Contributing to Severity and Mortality | Q33828481 | ||
Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials | Q34460803 | ||
Viral shedding and clinical illness in naturally acquired influenza virus infections | Q34695139 | ||
Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type | Q35531934 | ||
Incidence of influenza-like illness and severe acute respiratory infection during three influenza seasons in Bangladesh, 2008-2010. | Q35678827 | ||
Acute cardiac injury events ≤30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010-2012. | Q35793997 | ||
Morbidity, Mortality, and Seasonality of Influenza Hospitalizations in Egypt, November 2007-November 2014 | Q36126614 | ||
Complications of viral influenza | Q37122305 | ||
Multipathogen infections in hospitalized children with acute respiratory infections | Q37388653 | ||
Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain | Q37443062 | ||
Acute myocardial infarction and influenza: a meta-analysis of case-control studies | Q38574447 | ||
Influenza as a trigger for cardiovascular disease: An investigation of serotype, subtype and geographic location | Q38800824 | ||
Seasonality, timing, and climate drivers of influenza activity worldwide | Q38886210 | ||
Characterization of influenza outbreaks in Lebanon during the 2013/14 and 2014/15 seasons | Q39313744 | ||
The Hidden Burden of Influenza: A Review of the Extra-Pulmonary Complications of Influenza Infection | Q39458911 | ||
Hospitalization for Influenza A Versus B. | Q39480353 | ||
Rhabdomyolysis and acute renal failure associated with influenza virus type A. | Q40631810 | ||
Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. | Q41543622 | ||
Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial | Q41928469 | ||
Influenza vaccination and risk of respiratory failure in patients with chronic obstructive pulmonary disease: A nationwide population-based case-cohort study | Q41996399 | ||
Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection | Q42218621 | ||
Vaccine for prevention of mild and moderate-to-severe influenza in children | Q42249800 | ||
Influenza virus infections in Lebanese children in the 2007-2008 season. | Q43175084 | ||
Prevalence of human metapneumovirus and influenza virus infections among Japanese children during two successive winters | Q43177178 | ||
Acute encephalopathy associated with influenza A virus infection | Q44320944 | ||
Rhabdomyolysis and acute renal failure associated with influenza virus type B infection | Q45413372 | ||
Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season | Q45415593 | ||
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season | Q46159620 | ||
Estimating the burden of influenza-associated hospitalization and deaths in Oman (2012-2015). | Q46586814 | ||
Influenza-associated Severe Acute Respiratory Infections in Two Sentinel Sites in Lebanon - September 2015 to August 2016. | Q47448135 | ||
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection | Q47549279 | ||
Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: Systematic literature review and meta-analysis. | Q47570386 | ||
Vaccines for preventing influenza in healthy children | Q47638511 | ||
Association between influenza vaccination and reduced risks of major adverse cardiovascular events in elderly patients | Q47711057 | ||
A case of influenza type a myocarditis that presents with ST elevation MI, cardiogenic shock, acute renal failure, and rhabdomyolysis and with rapid recovery after treatment with oseltamivir and intra-aortic balloon pump support | Q50117526 | ||
Epidemiology of seasonal influenza in the Middle East and North Africa regions, 2010-2016: circulating influenza A and B viruses and spatial timing of epidemics. | Q50188939 | ||
Prevalence of Influenza A Infection in the Middle-East: A Systematic Review and Meta-analysis. | Q54289629 | ||
Study of 2009 H1N1 pandemic influenza virus as a possible causative agent of diabetes | Q57093702 | ||
Pandemic influenza and subsequent risk of type 1 diabetes: a nationwide cohort study | Q57094447 | ||
Clinical Features and Outcomes of Immunocompromised Children Hospitalized With Laboratory-Confirmed Influenza in the United States, 2011-2015 | Q57787701 | ||
Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons | Q57927674 | ||
The burden of influenza B: a structured literature review | Q57943670 | ||
Recommendations for Prevention and Control of Influenza in Children, 2018-2019 | Q59353351 | ||
Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017 | Q60730908 | ||
Seasonal influenza vaccination policies in the Eastern Mediterranean Region: Current status and the way forward | Q63916434 | ||
Influenza surveillance in Middle East, North, East and South Africa: Report of the 8th MENA Influenza Stakeholders Network | Q64111279 | ||
Impact of influenza on hospitalization rates in children with a range of chronic lung diseases | Q64117364 | ||
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa | Q64134362 | ||
Review of seasonal influenza vaccination in the Eastern Mediterranean Region: Policies, use and barriers. | Q64891236 | ||
Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007 | Q80151777 | ||
The effect of influenza vaccination on the incidence of chronic obstructive pulmonary disease exacerbations in the immediate postvaccination period | Q85056252 | ||
Vaccines against influenza WHO position paper – November 2012 | Q85607288 | ||
Prevention and Control of Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season | Q86185371 | ||
Effect of Influenza on Outcomes in Patients With Heart Failure | Q90903305 | ||
Prevalence and characteristics of acute respiratory virus infections in pediatric cancer patients | Q91579935 | ||
Comparative global epidemiology of influenza, respiratory syncytial and parainfluenza viruses, 2010-2015 | Q92022996 | ||
Molecular epidemiology and genetic characterization of influenza B virus in Lebanon during 2016-2018 | Q92041349 | ||
Pulmonary complications of influenza infection: a targeted narrative review | Q92201605 | ||
P433 | issue | 1 | |
P304 | page(s) | 339 | |
P577 | publication date | 2020-05-12 | |
P1433 | published in | BMC Infectious Diseases | Q15759919 |
P1476 | title | The burden of laboratory-confirmed influenza infection in Lebanon between 2008 and 2016: a single tertiary care center experience | |
P478 | volume | 20 |